The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Optimizing Patient Care and Research: The Amsterdam Dementia Cohort
Open accessAbstract
Since its opening in 2000, patient care and research go hand in hand at the Alzheimer center of the VU University Medical Center, both organized in such a way that they mutually strengthen each other. Our mission is to give patients a voice by lifting the stigma on dementia, to find new diagnostic and treatment strategies, and, ultimately, to cure diseases that cause dementia. Our healthcare pathway is uniquely designed to accommodate all necessary investigations for the diagnostic work-up of dementia in one day (one-stop shop). A second unique feature is that research has been fully integrated in the healthcare pathway. The resulting Amsterdam Dementia Cohort now includes over 4000 patients, and for the majority of these, we have MRI, EEG, blood (serum, plasma), DNA, and CSF available. The Amsterdam Dementia Cohort forms the basis of much of our research, which focuses on four major research lines: 1) variability in manifestation, 2) early diagnosis, 3) vascular factors, and 4) interventions. By answering research questions closely related to clinical practice, the results of our research can be looped back to improve clinical work-up for our patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Self-citationAlbert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152 · cited 1×
“In both sets of criteria, CSF biomarkers have now been incorporated as markers providing evidence of the Alzheimer pathophysiological process, ‘when available and deemed appropriate by the clinician’ [2, 9, 58, 59].”
BackgroundMild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Validity of the Trail Making Test as an Indicator of Organic Brain Damage
Reitan, R. M. (1958) · Perceptual and Motor Skills · doi:10.2466/pms.1958.8.3.271 · Cited by 7,928
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging
Fazekas, F., Chawluk, J., Alavi, A., Hurtig, H., & Zimmerman, R. (1987) · American Journal of Roentgenology · doi:10.2214/ajr.149.2.351 · Cited by 5,334
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221
Self-citationClassification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411
Self-citationClinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
L’examen Clinique en Psychologie
Rubé, P. (1959) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1959.13.4.989 · Cited by 3,302
Revising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869 · cited 1×
“In both sets of criteria, CSF biomarkers have now been incorporated as markers providing evidence of the Alzheimer pathophysiological process, ‘when available and deemed appropriate by the clinician’ [2, 9, 58, 59].”
BackgroundSelf-citationScheltens, P., Leys, D., Barkhof, F., Huglo, D., Weinstein, H. C., Vermersch, P., Kuiper, M., Steinling, M., Wolters, E. C., & Valk, J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.10.967 · Cited by 1,784
Self-citationMcKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (2011) · Neurology · doi:10.1212/01.wnl.0000400650.92875.cf · Cited by 1,495
CSF markers for incipient Alzheimer's disease
Blennow, K., & Hampel, H. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00530-1 · Cited by 1,291
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Mattsson, N. (2009) · JAMA · doi:10.1001/jama.2009.1064 · Cited by 1,176
Gélinas, I., Gauthier, L., McIntyre, M., & Gauthier, S. (1999) · The American Journal of Occupational Therapy · doi:10.5014/ajot.53.5.471 · Cited by 900
Sperling, R. A., Jack, C. R., Black, S. E., Frosch, M. P., Greenberg, S. M., Hyman, B. T., Scheltens, P., Carrillo, M. C., Thies, W., Bednar, M. M., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.05.2351 · Cited by 857
Self-citationA consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
Teunissen, C. E., Petzold, A., Bennett, J. L., Berven, F. S., Brundin, L., Comabella, M., Franciotta, D., Frederiksen, J. L., Fleming, J. O., Furlan, R., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c47cc2 · Cited by 845
Self-citationLongitudinal assessment of Aβ and cognition in aging and Alzheimer disease
Villemagne, V. L., Pike, K. E., Chételat, G., Ellis, K. A., Mulligan, R. S., Bourgeat, P., Ackermann, U., Jones, G., Szoeke, C., Salvado, O., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22248 · Cited by 833
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
Salloway, S., Sperling, R., Gilman, S., Fox, N. C., Blennow, K., Raskind, M., Sabbagh, M., Honig, L. S., Doody, R., van Dyck, C. H., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c67808 · Cited by 753
Amyloid deposition, hypometabolism, and longitudinal cognitive decline
Landau, S. M., Mintun, M. A., Joshi, A. D., Koeppe, R. A., Petersen, R. C., Aisen, P. S., Weiner, M. W., Jagust, W. J., & Initiative, F. T. A. D. N. (2012) · Annals of Neurology · doi:10.1002/ana.23650 · Cited by 727
Johnson, K. A., Minoshima, S., Bohnen, N. I., Donohoe, K. J., Foster, N. L., Herscovitch, P., Karlawish, J. H., Rowe, C. C., Carrillo, M. C., Hartley, D. M., et al. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.01.002 · Cited by 603
Pasquier, F., Leys, D., Weerts, J. G. E., Mounier-Vehier, F., Barkhof, F., & Scheltens, P. (2008) · European Neurology · doi:10.1159/000117270 · Cited by 525
Self-citationVisual assessment of posterior atrophy development of a MRI rating scale
Koedam, E. L. G. E., Lehmann, M., van der Flier, W. M., Scheltens, P., Pijnenburg, Y. A. L., Fox, N., Barkhof, F., & Wattjes, M. P. (2011) · European Radiology · doi:10.1007/s00330-011-2205-4 · Cited by 413
Self-citationStructural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion
Scheltens, P., Fox, N., Barkhof, F., & De Carli, C. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00002-9 · Cited by 410
Self-citationResting-state fMRI changes in Alzheimer's disease and mild cognitive impairment
Binnewijzend, M. A. A., Schoonheim, M. M., Sanz-Arigita, E., Wink, A. M., van der Flier, W. M., Tolboom, N., Adriaanse, S. M., Damoiseaux, J. S., Scheltens, P., van Berckel, B. N. M., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.07.003 · Cited by 384
Self-citationCSF biomarker variability in the Alzheimer's Association quality control program
Mattsson, N., Andreasson, U., Persson, S., Carrillo, M. C., Collins, S., Chalbot, S., Cutler, N., Dufour‐Rainfray, D., Fagan, A. M., Heegaard, N. H. H., et al. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.01.010 · Cited by 382
Self-citationFrontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Faber, R., & Neary, D. (1999) · Neurology · doi:10.1212/wnl.53.5.1158-b · Cited by 363
Visual association test to detect early dementia of the Alzheimer type
Lindeboom, J. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.2.126 · Cited by 360
del Campo, M., Mollenhauer, B., Bertolotto, A., Engelborghs, S., Hampel, H., Simonsen, A. H., Kapaki, E., Kruse, N., Le Bastard, N., Lehmann, S., et al. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.46 · Cited by 343 · cited 1×
“Our Alzheimer center has therefore initiated one of the first quality control rounds and actively participates in ongoing quality control programs [53] [54] [55] [56] [57].”
BackgroundSelf-citationMulder, C., Verwey, N. A., van der Flier, W. M., Bouwman, F. H., Kok, A., van Elk, E. J., Scheltens, P., & Blankenstein, M. A. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.130518 · Cited by 335
Self-citationBlood–brain barrier P-glycoprotein function in Alzheimer's disease
van Assema, D. M. E., Lubberink, M., Bauer, M., van der Flier, W. M., Schuit, R. C., Windhorst, A. D., Comans, E. F. I., Hoetjes, N. J., Tolboom, N., Langer, O., et al. (2012) · Brain · doi:10.1093/brain/awr298 · Cited by 318
Self-citationBrain microbleeds and Alzheimer’s disease: innocent observation or key player?
Cordonnier, C., & van der Flier, W. M. (2011) · Brain · doi:10.1093/brain/awq321 · Cited by 310
Efficacy of Souvenaid in Mild Alzheimer's Disease: Results from a Randomized, Controlled Trial
Scheltens, P., Twisk, J. W. R., Blesa, R., Scarpini, E., von Arnim, C. A. F., Bongers, A., Harrison, J., Swinkels, S. H. N., Stam, C. J., de Waal, H., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-121189 · Cited by 306
Self-citationPrevalence and severity of microbleeds in a memory clinic setting
Cordonnier, C., van der Flier, W. M., Sluimer, J. D., Leys, D., Barkhof, F., & Scheltens, P. (2006) · Neurology · doi:10.1212/01.wnl.0000210535.20297.ae · Cited by 305
Self-citationEfficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial
Scheltens, P., Kamphuis, P. J. G. H., Verhey, F. R. J., Olde Rikkert, M. G. M., Wurtman, R. J., Wilkinson, D., Twisk, J. W. R., & Kurz, A. (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2009.10.003 · Cited by 299
Self-citationBinnewijzend, M. A. A., Kuijer, J. P. A., Benedictus, M. R., van der Flier, W. M., Wink, A. M., Wattjes, M. P., van Berckel, B. N. M., Scheltens, P., & Barkhof, F. (2013) · Radiology · doi:10.1148/radiol.12120928 · Cited by 260
Self-citationDiagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
(2005) · Neurology · doi:10.1212/wnl.65.12.1992-a · Cited by 240
Letterfluency: psychometrische eigenschappen en Nederlandse normen
Schmand, B., Groenink, S. C., & den Dungen, M. (2008) · Tijdschrift voor Gerontologie en Geriatrie · doi:10.1007/bf03078128 · Cited by 212
Amyloid β(1–42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease
Schoonenboom, N. S. M., Pijnenburg, Y. A. L., Mulder, C., Rosso, S. M., Van Elk, E. J., Van Kamp, G. J., Van Swieten, J. C., & Scheltens, P. (2004) · Neurology · doi:10.1212/01.wnl.0000123249.58898.e0 · Cited by 181
Self-citationVerwey, N. A., van der Flier, W. M., Blennow, K., Clark, C., Sokolow, S., De Deyn, P. P., Galasko, D., Hampel, H., Hartmann, T., Kapaki, E., et al. (2009) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/acb.2009.008232 · Cited by 169
Self-citationRelationship of Cerebrospinal Fluid Markers to11C-PiB and18F-FDDNP Binding
Tolboom, N., van der Flier, W. M., Yaqub, M., Boellaard, R., Verwey, N. A., Blankenstein, M. A., Windhorst, A. D., Scheltens, P., Lammertsma, A. A., & van Berckel, B. N. M. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.064360 · Cited by 160
Self-citationLongitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET
Ossenkoppele, R., Tolboom, N., Foster-Dingley, J. C., Adriaanse, S. F., Boellaard, R., Yaqub, M., Windhorst, A. D., Barkhof, F., Lammertsma, A. A., Scheltens, P., et al. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2102-3 · Cited by 160
Self-citationMRI Biomarkers of Vascular Damage and Atrophy Predicting Mortality in a Memory Clinic Population
Henneman, W. J. P., Sluimer, J. D., Cordonnier, C., Baak, M. M. E., Scheltens, P., Barkhof, F., & van der Flier, W. M. (2008) · Stroke · doi:10.1161/strokeaha.108.516286 · Cited by 148
Self-citationA new informant‐based questionnaire for instrumental activities of daily living in dementia
Sikkes, S. A. M., Klerk, E. S. M. D. L., Pijnenburg, Y. A. L., Gillissen, F., Romkes, R., Knol, D. L., Uitdehaag, B. M. J., & Scheltens, P. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.08.006 · Cited by 146
Self-citationIncidence of cerebral microbleeds: A longitudinal study in a memory clinic population
Goos, J. D. C., Henneman, W. J. P., Sluimer, J. D., Vrenken, H., Sluimer, I. C., Barkhof, F., Blankenstein, M. A., Scheltens, P., & van der Flier, W. M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e396ea · Cited by 137
Self-citationDetection of Alzheimer Pathology In Vivo Using Both 11C-PIB and 18F-FDDNP PET
Tolboom, N., Yaqub, M. M., van der Flier, W. M., Boellaard, R., Luurtsema, G., Windhorst, A. D., Barkhof, F., Scheltens, P., Lammertsma, A. A., & van Berckel, B. N. M. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.056499 · Cited by 137
Self-citationCerebral Microbleeds Are Predictive of Mortality in the Elderly
Altmann‐Schneider, I., Trompet, S., de Craen, A. J. M., van Es, A. C. G. M., Jukema, J. W., Stott, D. J., Sattar, N. A., Westendorp, R. G. J., van Buchem, M. A., & van der Grond, J. (2011) · Stroke · doi:10.1161/strokeaha.110.595611 · Cited by 129
Sikkes, S. A. M., Knol, D. L., Pijnenburg, Y. A. L., Klerk, E. S. M. D. L., Uitdehaag, B. M. J., & Scheltens, P. (2013) · Neuroepidemiology · doi:10.1159/000346277 · Cited by 110
Self-citationLehmann, M., Koedam, E., Barnes, J., Bartlett, J. W., Ryan, N. S., Pijnenburg, Y. A. L., Barkhof, F., Wattjes, M. P., Scheltens, P., & Fox, N. C. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.04.003 · Cited by 100
Self-citationMicrobleeds do not affect rate of cognitive decline in Alzheimer disease
van der Vlies, A. E., Goos, J. D. C., Barkhof, F., Scheltens, P., & van der Flier, W. M. (2012) · Neurology · doi:10.1212/wnl.0b013e3182661f91 · Cited by 80
Self-citationTeunissen, C. E., Verwey, N. A., Kester, M. I., van Uffelen, K. W. J., & Blankenstein, M. A. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/635053 · Cited by 72
Self-citationScheltens, P., & van de Pol, L. A. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302562 · Cited by 71
Self-citationAssociations between Patterns of EEG Abnormalities and Diagnosis in a Large Memory Clinic Cohort
Liedorp, M., van der Flier, W. M., Hoogervorst, E. L. J., Scheltens, P., & Stam, C. J. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000182422 · Cited by 62
Self-citationMøst, E. I. S., Scheltens, P., & Someren, E. J. W. V. (2010) · Trials · doi:10.1186/1745-6215-11-19 · Cited by 61
Self-citation[Digit series and Knox cubes as concentration tests for elderly subjects].
Lindeboom, J., & Matto, D. (1994) · PubMed · Cited by 55
EEG abnormalities in early and late onset Alzheimer's disease: understanding heterogeneity
de Waal, H., Stam, C. J., Blankenstein, M. A., Pijnenburg, Y. A. L., Scheltens, P., & van der Flier, W. M. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.216432 · Cited by 53
Self-citationAmyloid and its association with default network integrity in Alzheimer's disease
Adriaanse, S. M., Sanz‐Arigita, E., Binnewijzend, M. A. A., Ossenkoppele, R., Tolboom, N., van Assema, D. M. E., Wink, A. M., Boellaard, R., Yaqub, M. M., Windhorst, A. D., et al. (2012) · Human Brain Mapping · doi:10.1002/hbm.22213 · Cited by 47
Self-citationInitiative, A. T. A. D. N., Boutet, C., Marie Chupin, A., Colliot, O., Sarazin, M., Mutlu, G., Drier, A., Pellot, A., Dormont, D., & Lehéricy, S. (2012) · Neuroradiology · doi:10.1007/s00234-012-1058-0 · Cited by 46
Differential association of [ 11 C]PIB and [ 18 F]FDDNP binding with cognitive impairment
Tolboom, N., van der Flier, W. M., Yaqub, M. M., Koene, T., Boellaard, R., Windhorst, A. D., Scheltens, P., Lammertsma, A. A., & van Berckel, B. N. M. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c679cc · Cited by 46
Self-citationKrudop, W. A., Kerssens, C. J., Dols, A., Prins, N. D., Möller, C., Schouws, S. N. T. M., Barkhof, F., van Berckel, B. N. M., Teunissen, C. E., van der Flier, W. M., et al. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.02.002 · Cited by 40
Self-citationVanderstichele, H., Shaw, L. M. J., Vandijck, M. L. J., Jeromin, A., Zetterberg, H., Blennow, K., Teunissen, C. E., & Engelborghs, S. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.201830 · Cited by 22
Self-citationStudy protocol: EXERcise and Cognition In Sedentary adults with Early-ONset dementia (EXERCISE-ON)
Hooghiemstra, A. M., Eggermont, L. H. P., Scheltens, P., van der Flier, W. M., Bakker, J., de Greef, M. H., Koppe, P. A., & Scherder, E. (2012) · BMC Neurology · doi:10.1186/1471-2377-12-75 · Cited by 21
Self-citationMicrobleeds do not affect rate of cognitive decline in Alzheimer disease
Martínez‐Ramírez, S., Greenberg, S. M., & Viswanathan, A. (2013) · Neurology · doi:10.1212/wnl.0b013e31828b8c16 · Cited by 9
Cited by
Modern network science of neurological disorders
Stam, C. J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3801 · Cited by 1,307
Self-citationClinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group
Dubois, B., Villain, N., Frisoni, G. B., Rabinovici, G. D., Sabbagh, M., Cappa, S., Bejanin, A., Bombois, S., Epelbaum, S., Teichmann, M., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00066-1 · Cited by 1,051
Vermunt, L., Sikkes, S. A. M., van den Hout, A., Handels, R., Bos, I., van der Flier, W. M., Kern, S., Ousset, P., Maruff, P., Skoog, I., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.04.001 · Cited by 570
“(Gothenburg H70) provided data for the study [24-29].”
BackgroundSelf-citationOssenkoppele, R., Pijnenburg, Y. A. L., Perry, D. C., Cohn-Sheehy, B. I., Scheltens, N. M. E., Vogel, J. W., Kramer, J. H., van der Vlies, A. E., Joie, R. L., Rosen, H. J., et al. (2015) · Brain · doi:10.1093/brain/awv191 · Cited by 548
Self-citationDrug development in Alzheimer’s disease: the path to 2025
Cummings, J., Aisen, P. S., DuBois, B., Frölich, L., Jack, C. R., Jones, R. W., Morris, J. C., Raskin, J., Dowsett, S. A., & Scheltens, P. (2016) · Alzheimer's Research & Therapy · doi:10.1186/s13195-016-0207-9 · Cited by 459
Self-citation
Metadata
- Authors
- van der Flier, W. M., Pijnenburg, Y. A. L., Prins, N., Lemstra, A. W., Bouwman, F. H., Teunissen, C. E., van Berckel, B. N. M., Stam, C. J., Barkhof, F., Visser, P. J., van Egmond, E., & Scheltens, P.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2014-06-04
- Volume
- 41
- Issue
- 1
- Pages
- 313-327
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1577433680
- Cited by
- 398
- References
- 71
- FWCI
- 23.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.